Patent ID: 7803393
Filing Date: 2010-09-28
Classification: A61L,B29C,B29L,C07K

Abstract:
1. An implant prepared by a process comprising: subjecting a bioresorbable polymeric substrate to a gas-plasma treatment, wherein the bioresorbable polymeric substrate comprises a polylactide polymeric material, wherein subjecting the substrate to the gas-plasma treatment comprises exposing the substrate to a reactive gas, wherein the reactive gas comprises oxygen, and wherein the supplied energy during the gas-plasma treatment is between about 5 kJ and about 10 kJ at a temperature of less than about 50 C, a pressure between about 0.01 torr and about 10 torr, and a discharge frequency between about 13 MHz and about 14 MHz, wherein the reactive gas comprises an oxygen content sufficient to provide oxide free radicals on the substrate when the substrate is subjected to the gas-plasma treatment; and exposing the substrate subjected to the gas-plasma treatment to living cells that produce vascular endothelial growth factor (VEGF), wherein a portion of the living cells that produce VEGF become coupled to the substrate; and wherein the living cells that produce VEGF coupled to the substrate subjected to the gas-plasma treatment produce more VEGF than living cells that produce VEGF when coupled to the substrate not subjected to the gas-plasma treatment.